Michael H. Davidson - Jun 20, 2024 Form 4 Insider Report for NewAmsterdam Pharma Co N.V. (NAMS)

Role: Chief Executive Officer, Director
Signature: /s/ Louise Kooij by Power of Attorney from Michael H. Davidson
Stock symbol: NAMS
Transactions as of: Jun 20, 2024
Transactions value $: $86,309
Form type: 4
Date filed: 6/24/2024, 08:30 AM
Previous filing: Sep 27, 2024
Next filing: Aug 8, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NAMS	Ordinary Shares	Purchase	$86.3K	+5K	+2.5%	$17.26	205K	Jun 20, 2024	Direct	F1
holding	NAMS	Ordinary Shares						609K	Jun 20, 2024	See footnote	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.115 to $17.60, inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, specific trade amounts and pricing within the range set forth in this footnote at which the transaction was effected.
F2	The 608,779 Ordinary Shares are held of record by Stichting Administratiekantoor EPNAP ("STAK EPNAP") and are subject to forfeiture underlying depositary receipts issued by STAK EPNAP. STAK EPNAP has sole voting and investment power over the 608,779 Ordinary Shares underlying the depositary receipts and are presented here because the depositary receipts can be cancelled by the board of directors of STAK EPNAP at any time as a consequence of which the Reporting Person will become the beneficial owner of the securities underlying the depositary receipts.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.115 to $17.60, inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, specific trade amounts and pricing within the range set forth in this footnote at which the transaction was effected.

The 608,779 Ordinary Shares are held of record by Stichting Administratiekantoor EPNAP ("STAK EPNAP") and are subject to forfeiture underlying depositary receipts issued by STAK EPNAP. STAK EPNAP has sole voting and investment power over the 608,779 Ordinary Shares underlying the depositary receipts and are presented here because the depositary receipts can be cancelled by the board of directors of STAK EPNAP at any time as a consequence of which the Reporting Person will become the beneficial owner of the securities underlying the depositary receipts.